Elie R.
- Country
- France
- Department
- Medical Oncology and Hematology
Research Overview
Data & Insights
Has run more than one trial at 0 of 5 partner sites.
Specializations
Advanced Breast Cancer
This investigator specializes in treating hormone receptor-positive and HER2-negative advanced breast cancer, exploring innovative therapeutic combinations including targeted therapies and endocrine treatments.
- Novel therapeutic combinations
- Hormone receptor-positive disease management
- Treatment resistance strategies
The research focus includes evaluating new therapeutic agents for advanced breast cancer treatment.
Triple Negative Breast Cancer
The investigator conducts research in early-stage triple-negative breast cancer, particularly focusing on immunotherapy approaches and the role of tumor-infiltrating lymphocytes.
- Immunotherapy strategies
- Personalized treatment approaches
- Surveillance protocols
Their work examines age-specific treatment strategies and biomarker-guided therapy selection.
Metastatic Breast Cancer
Research activities encompass advanced and metastatic breast cancer treatments, with particular attention to combination therapy approaches and novel therapeutic agents.
- First-line treatment strategies
- Combination therapy optimization
- Treatment efficacy assessment
The investigator evaluates innovative treatment combinations for metastatic disease management.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.